Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comparative analysis of consolidation strategies after induction chemotherapy in primary central nervous system lymphoma

Yuna Lee, Hyungwoo Cho, Jaewon Hyung, In Hye Song, Heounjeong Go, Ji Eun Park, Ho Sung Kim, Minyoung Oh, Jae Seung Kim, Jin-Sook Ryu, Sangjoon Chong, Sang Woo Song, Young-Hoon Kim, Young Hyun Cho, Seok Ho Hong, Jeong Hoon Kim, Dok Hyun Yoon

Blood (2025) 146 (Supplement 1): 5457.

https://doi.org/10.1182/blood-2025-5457

Published: 2025

Journal Articles

Clinical outcomes associated with conditioning regimens in patients with primary central nervous system lymphoma undergoing consolidation autologous stem cell transplantation

Blood (2025) 146 (Supplement 1): 5455.

https://doi.org/10.1182/blood-2025-5455

Published: 2025

Journal Articles

Phase 1 study of GCC2005, an allogeneic CD5-directed CAR-NK therapy, for patients with Relapsed/Refractory NK/T-cell malignancies

Won-Seog Kim, Dok Hyun Yoon, Youngil Koh, Seok Jin Kim, Sang Eun Yoon, Hyungwoo Cho, Jaewon Hyung, Ja Min Byun, Hyesung Jeon, Seungryel Han

Blood (2025) 146 (Supplement 1): 1043.

https://doi.org/10.1182/blood-2025-1043

Published: 2025

Journal Articles

Phase II study of lenalidomide in combination with rituximab, cyclophosphadmie, doxorubicin, vincristine, and prenisone (R-CHOP) for central nervous system prophylaxis in high-risk diffuse large B cell lymphoma

Hyungwoo Cho, Jaewon Hyung, Hyeon-Seok Eom, Sung-Nam Lim, Hye Jin Kang, Myung-Won Lee, Young Rok Do, Seong Hyun Jeong, Hyo Jung Kim, Youngil Koh, Seong Yoon Yi, Ka-Won Kang, Min Kyoung Kim, Jae-Yong Kwak, Gyeong-Won Lee, Dok Hyun Yoon

Blood (2025) 146 (Supplement 1): 1915.

https://doi.org/10.1182/blood-2025-1915

Published: 2025

Journal Articles

Phase I/II study of zanubrutinib in combination with rituximab, ifosfamide, carboplatin, and etoposide (ZR-ICE) in Relapsed/Refractory diffuse large B-cell lymphoma: Results of the Phase I portion

Hyungwoo Cho, Jaewon Hyung, Dong Won Baek, Ho Sup Lee, Hye Jin Kang, Gyeong-Won Lee, Jeong-Ok Lee, Myung-Won Lee, Sung-Nam Lim, Sung Yong Oh, Ho-Jin Shin, Kwai Han Yoo, Young Rok Do, Jae-Yong Kwak, Yong-pyo Lee, Deok-Hwan Yang, Dok Hyun Yoon

Blood (2025) 146 (Supplement 1): 3702.

https://doi.org/10.1182/blood-2025-3702

Published: 2025

Journal Articles

Trial in progress: A Phase 2a Study of GI-102 (CD80/IL2v3) as a consolidation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma following anti-CD19 chimeric antigen receptor T-cell therapy (CARNATION trial)

Dok Hyun Yoon, Hyungwoo Cho, Jaewon Hyung, Yoon Seok Choi, Youngwoo Jeon, Seok Jin Kim, Youngil Koh, Nari Yun, Woohyung Lee, Chanmi Kim, Myoung Ho Jang

Blood (2025) 146 (Supplement 1): 2399.

https://doi.org/10.1182/blood-2025-2399

Published: 2025

Journal Articles

Prognostic value of interim PET in patients with extranodal natural killer/T-cell lymphoma treated with non-anthracycline containing l-asparaginase based regimen

Sojin Kim, Hyungwoo Cho, Dok Hyun Yoon, Jaewon Hyung, Kyung Won Kim, Chan-sik Park, Heounjeong Go, In Hye Song, Eun Jin Chae, Yoon Se Lee, Minsu Kwon, Sang-Wook Lee, Jin-Sook Ryu

Blood (2025) 146 (Supplement 1): 3632.

https://doi.org/10.1182/blood-2025-3632

Published: 2025

Journal Articles

Clinical significance of blood EBV-DNA in peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) and EBV-positive nodal T-cell lymphoma

Hyunseok Yoon, Sejin Kim, So Heun Lee, Jaewon Hyung, Hyungwoo Cho, Chan-sik Park, In Hye Song, Heounjeong Go, Eun Jin Chae, Kyung Won Kim, Jin-Sook Ryu, Sang-Wook Lee, Dok Hyun Yoon

Blood (2025) 146 (Supplement 1): 3654.

https://doi.org/10.1182/blood-2025-3654

Published: 2025

Journal Articles

Prognostic Analysis of Colorectal Extranodal Marginal Zone Lymphoma of MALT Type: Clinical Outcomes and Implications

Yeokyeong Shin, Jaewon Hyung, Hyungwoo Cho, Shin Kim, Chan-Sik Park, Heounjeong Go, In Hye Song, Jin-Sook Ryu, Sang-wook Lee, Dok Hyun Yoon

Blood (2024) 144 (Supplement 1): 1659.

https://doi.org/10.1182/blood-2024-209435

Published: 2024

Journal Articles

Interim PET-CT Scan to Improve Risk Modeling for Patients with Extranodal Natural Killer/T-Cell Lymphoma Treated with Non-Anthracycline Containing L-Asparaginase Based Regimen

Jaewon Hyung, Jwa Hoon Kim, Hyungwoo Cho, Jin Sook Ryu, Jooryung Huh, Chan-Sik Park, Sang-wook Lee, Yoon Se Lee, Cheolwon Suh

Blood (2022) 140 (Supplement 1): 9404–9405.

https://doi.org/10.1182/blood-2022-159284

Published: 2022

Journal Articles

Increased Serum Beta-2 Microglobulin during Induction Chemotherapy Associated with Poor Prognosis in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, MD, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Sang Wook Lee, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 2995.

https://doi.org/10.1182/blood-2018-99-118221

Published: 2018

Journal Articles

High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, MD, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Sang Wook Lee, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5762.

https://doi.org/10.1182/blood-2018-99-118222

Published: 2018

Journal Articles

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5506.

https://doi.org/10.1182/blood.V130.Suppl_1.5506.5506

Published: 2017

Journal Articles

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 3300.

https://doi.org/10.1182/blood.V130.Suppl_1.3300.3300

Published: 2017

Journal Articles

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4139.

https://doi.org/10.1182/blood.V130.Suppl_1.4139.4139

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comparative analysis of consolidation strategies after induction chemotherapy in primary central nervous system lymphoma

Clinical outcomes associated with conditioning regimens in patients with primary central nervous system lymphoma undergoing consolidation autologous stem cell transplantation

Phase 1 study of GCC2005, an allogeneic CD5-directed CAR-NK therapy, for patients with Relapsed/Refractory NK/T-cell malignancies

Phase II study of lenalidomide in combination with rituximab, cyclophosphadmie, doxorubicin, vincristine, and prenisone (R-CHOP) for central nervous system prophylaxis in high-risk diffuse large B cell lymphoma

Phase I/II study of zanubrutinib in combination with rituximab, ifosfamide, carboplatin, and etoposide (ZR-ICE) in Relapsed/Refractory diffuse large B-cell lymphoma: Results of the Phase I portion

Trial in progress: A Phase 2a Study of GI-102 (CD80/IL2v3) as a consolidation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma following anti-CD19 chimeric antigen receptor T-cell therapy (CARNATION trial)

Prognostic value of interim PET in patients with extranodal natural killer/T-cell lymphoma treated with non-anthracycline containing l-asparaginase based regimen

Clinical significance of blood EBV-DNA in peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) and EBV-positive nodal T-cell lymphoma

Prognostic Analysis of Colorectal Extranodal Marginal Zone Lymphoma of MALT Type: Clinical Outcomes and Implications

Interim PET-CT Scan to Improve Risk Modeling for Patients with Extranodal Natural Killer/T-Cell Lymphoma Treated with Non-Anthracycline Containing L-Asparaginase Based Regimen

Increased Serum Beta-2 Microglobulin during Induction Chemotherapy Associated with Poor Prognosis in Primary Central Nervous System Lymphoma

High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only